These data were corroborated in vivo, with anti-tumor T cell activation and effector functions improving with the depletion of CD73, likely through diminishing intratumoral adenosine concentrations—thus allowing for proper T cell activation and cytolytic functions [99]. This evidence concerns the gene NT5E and neoplasm.